Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:1692-1697
doi: 10.1161/01.STR.0000016966.89226.67
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chrissobolis, S.
Right arrow Articles by Sobey, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chrissobolis, S.
Right arrow Articles by Sobey, C. G.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Ion channels/membrane transport
Right arrow Other Vascular biology

(Stroke. 2002;33:1692.)
© 2002 American Heart Association, Inc.


Original Contributions

Inhibitory Effects of Protein Kinase C on Inwardly Rectifying K+- and ATP-Sensitive K+ Channel-Mediated Responses of the Basilar Artery

Sophocles Chrissobolis, BSc(Hons) Christopher G. Sobey, PhD

From the Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.

Correspondence to Christopher G. Sobey, PhD, Department of Pharmacology, University of Melbourne, Parkville, Victoria 3010, Australia. E-mail cgsobey{at}unimelb.edu.au

Background and Purpose The structurally related, inwardly rectifying K+ (KIR) channel and the ATP-sensitive K+ (KATP) channel are important modulators of cerebral artery tone. Although protein kinase C (PKC) activators have been shown to inhibit these channels with the use of patch-clamp electrophysiology, effects of PKC on K+ channel function in intact cerebral blood vessels are unknown. We therefore tested whether pharmacological alteration of PKC activity affects cerebral vasodilator responses to KIR and/or KATP channel activators in vivo.

Methods We measured changes in basilar artery diameter using a cranial window preparation in anesthetized rats. In addition, intracellular recordings of smooth muscle membrane potential were made in isolated basilar arteries.

Results K+ (5 to 15 mmol/L) and aprikalim (1 to 10 µmol/L) each elicited reproducible vasodilatation. The PKC activator phorbol-12,13-dibutyrate (PdBu) (50 nmol/L) inhibited responses to K+ (by 40% to 55%) and aprikalim (by 40% to 70%), whereas responses to papaverine were unaffected. The PKC inhibitor calphostin C (0.1 µmol/L) augmented responses to K+ (by 2- to 3-fold) and aprikalim (2-fold) but not papaverine. In addition, K+ (5 mmol/L) and aprikalim (3 µmol/L) each hyperpolarized the basilar artery. PdBu inhibited these responses to aprikalim by 45% but had no effect on K+-induced hyperpolarization.

Conclusions These data suggest that both basal and stimulated PKC activity inhibit KIR and KATP channel–mediated cerebral vasodilatation in vivo. The inhibitory effect on KATP channel–mediated vasodilatation occurs at least partly by inhibition of hyperpolarization mediated by KATP channels. PKC inhibits K+-induced vasodilatation without affecting hyperpolarization, suggesting that the inhibitory effect of PKC on vasodilator responses to K+ does not involve altered KIR channel function.


Key Words: basilar artery • potassium • potassium channels • protein kinases • rats




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. Zhou, X.-L. Wang, K. G. Lamping, and H.-C. Lee
Inhibition of Protein Kinase Cbeta Protects against Diabetes-Induced Impairment in Arachidonic Acid Dilation of Small Coronary Arteries
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Budzyn, M. Paull, P. D. Marley, and C. G. Sobey
Segmental Differences in the Roles of Rho-Kinase and Protein Kinase C in Mediating Vasoconstriction
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 791 - 796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Ye, W. Zhou, and H.-C. Lee
Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H358 - H364.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Kinoshita, T. Azma, K. Nakahata, H. Iranami, Y. Kimoto, M. Dojo, O. Yuge, and Y. Hatano
Inhibitory Effect of High Concentration of Glucose on Relaxations to Activation of ATP-Sensitive K+ Channels in Human Omental Artery
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2290 - 2295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Erdos, J. A. Snipes, B. Kis, A. W. Miller, and D. W. Busija
Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1456 - R1461.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Kinoshita, K. Nakahata, M. Dojo, Y. Kimoto, and Y. Hatano
Lidocaine Impairs Vasodilation Mediated by Adenosine Triphosphate-Sensitive K+ Channels but Not by Inward Rectifier K+ Channels in Rat Cerebral Microvessels
Anesth. Analg., September 1, 2004; 99(3): 904 - 909.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Erdos, J. A. Snipes, A. W. Miller, and D. W. Busija
Cerebrovascular Dysfunction in Zucker Obese Rats Is Mediated by Oxidative Stress and Protein Kinase C
Diabetes, May 1, 2004; 53(5): 1352 - 1359.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Chrissobolis and C. G. Sobey
Influence of Gender on K+-Induced Cerebral Vasodilatation
Stroke, March 1, 2004; 35(3): 747 - 752.
[Abstract] [Full Text] [PDF]